Cornelia M Weyand Selected Research

Giant Cell Arteritis (Horton Disease)

1/2022	Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Noninflammatory Aortic Aneurysms.
1/2022	Large-vessel vasculitis.
1/2022	Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study.
1/2020	Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.
1/2019	CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis.
1/2017	Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients.
1/2016	NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.
8/2011	Giant cell arteritis: immune and vascular aging as disease risk factors.
1/2011	Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis.
1/2011	IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cornelia M Weyand Research Topics

Disease

37	Inflammation (Inflammations) 01/2022 - 05/2002
32	Rheumatoid Arthritis 02/2022 - 01/2003
21	Giant Cell Arteritis (Horton Disease) 01/2022 - 01/2002
15	Vasculitis (Vasculitides) 01/2022 - 04/2005
7	Infections 01/2022 - 05/2007
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2003
7	Synovitis 12/2020 - 07/2004
7	Hyperplasia 01/2019 - 09/2003
5	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2016 - 06/2009
5	Atherosclerosis 10/2015 - 09/2005
5	Acute Coronary Syndrome 11/2010 - 02/2002
5	Atherosclerotic Plaque (Atheroma) 11/2010 - 05/2005
4	Ischemia 01/2022 - 09/2003
4	Hypertension (High Blood Pressure) 01/2018 - 12/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 03/2016 - 12/2006
3	Neoplasms (Cancer) 01/2022 - 02/2015
3	Takayasu Arteritis (Arteritis, Takayasu's) 01/2022 - 02/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 03/2016
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018 - 09/2008
3	Granuloma 05/2015 - 11/2002
3	Pathologic Constriction (Stenosis) 12/2013 - 04/2005
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022 - 01/2004
2	Aneurysm (Aneurysms) 01/2022 - 09/2006
2	Aortitis 01/2022 - 09/2006
2	Virus Diseases (Viral Diseases) 01/2021 - 10/2007
2	Arthritis (Polyarthritis) 12/2009 - 11/2008
2	Acute-Phase Reaction 09/2003 - 01/2002
1	Psoriatic Arthritis 02/2022
1	Nausea 01/2022
1	Hemorrhage 01/2022
1	Fatigue 01/2022
1	AIDS-Related Complex (ARC) 10/2021
1	Whooping Cough (Pertussis) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Disease Progression 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020

Drug/Important Bio-Agent (IBA)

22	CytokinesIBA 12/2021 - 01/2002
11	AntigensIBA 01/2022 - 08/2003
9	LigandsIBA 01/2018 - 04/2005
8	Phenobarbital (Luminal)FDA Link 01/2022 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 06/2005
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2016
5	AutoantibodiesIBA 01/2021 - 01/2003
5	Phosphotransferases (Kinase)IBA 01/2019 - 06/2009
5	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2002
5	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 10/2009
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021 - 12/2009
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 09/2003
4	GlucocorticoidsIBA 01/2017 - 10/2006
4	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2009 - 04/2005
4	ChemokinesIBA 06/2005 - 11/2002
3	Adenosine Triphosphate (ATP)IBA 12/2020 - 09/2013
3	Antiviral Agents (Antivirals)IBA 11/2019 - 10/2007
3	EnzymesIBA 01/2018 - 02/2015
3	AutoantigensIBA 06/2012 - 01/2008
3	Chemokine CX3CL1IBA 10/2007 - 05/2005
3	HLA-DRB1 Chains (HLA DRB1)IBA 09/2006 - 01/2004
2	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 01/2019
2	Biological ProductsIBA 01/2022 - 08/2011
2	Pharmaceutical PreparationsIBA 01/2022 - 05/2017
2	Peptides (Polypeptides)IBA 01/2021 - 06/2012
2	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2004
2	InterleukinsIBA 01/2018 - 03/2006
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2017
2	Monoclonal AntibodiesIBA 01/2018 - 01/2003
2	AntibodiesIBA 01/2018 - 01/2003
2	VaccinesIBA 01/2018 - 01/2012
2	Angiotensin IIIBA 01/2018 - 12/2010
2	Oxidants (Oxidizing Agents)IBA 03/2016 - 01/2016
2	LipidsIBA 05/2015 - 01/2010
2	PhosphofructokinasesIBA 02/2015 - 09/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2011 - 03/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2010 - 12/2006
2	SteroidsIBA 02/2010 - 01/2008
2	DNA Repair EnzymesIBA 10/2009 - 06/2009
2	InterferonsIBA 10/2007 - 12/2006
2	Interferon-alpha (Interferon Alfa)IBA 10/2007 - 12/2006
2	Immunoglobulins (Immunoglobulin)IBA 06/2005 - 07/2003
2	HLA-DRB1*04 antigenIBA 01/2005 - 11/2003
2	HLA-DR Antigens (HLA-DR)IBA 08/2003 - 05/2002
1	ChromatinIBA 02/2022
1	Janus Kinase 3IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	baricitinibIBA 01/2022
1	Aspartic Acid (Aspartate)FDA Link 12/2021
1	CalciumIBA 10/2021
1	Calcium Channels (Calcium Channel)IBA 10/2021
1	Arachidonic Acid (Vitamin F)IBA 10/2021
1	Sirtuin 1IBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	AcetyltransferasesIBA 12/2020
1	TubulinIBA 12/2020

Therapy/Procedure

12	Therapeutics 01/2022 - 09/2003
2	Immunomodulation 01/2020 - 01/2014
2	Immunotherapy 05/2017 - 06/2005